In the last century, antibiotics have been one of the most important discoveries for defeating numerous types of bacteria, but in recent times, microbes have become increasingly antibiotic resistant, causing severe consequences for human beings. The scientific community has been operating in this area for many years, developing projects always more focused on a multidisciplinary collaboration among partners. One of the most recent examples is the new cross border project between Italy and France, financed in 2013 by the European Union. It was established with the goal of fighting antibiotic resistances and optimizing antibiotic usage and patients’ care in both countries. These goals can only be achieved by comparison of differences between the two countries in prescribing patterns and usage of antibiotics, and related emerging inconveniences and disadvantages. In order to make the evaluation as efficient and automated as possible, a relevant part of this project is placed in the IT field. For this purpose, a highly normalized and standardized database was designed, managed by a web platform that collects data concerning antibiotic resistance and data on surveys among populations at risk. The proposed platform is at a prototypal level, currently available on the internet. 64 patients have already been inserted.
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient
PUPELLA, VALERIA;TAGLIATI, ALESSANDRO;SECONDO, GIOVANNI;DENTONE, CHIARA;FERREA, GIUSEPPE ANGELO;GIACOMINI, MAURO
2014-01-01
Abstract
In the last century, antibiotics have been one of the most important discoveries for defeating numerous types of bacteria, but in recent times, microbes have become increasingly antibiotic resistant, causing severe consequences for human beings. The scientific community has been operating in this area for many years, developing projects always more focused on a multidisciplinary collaboration among partners. One of the most recent examples is the new cross border project between Italy and France, financed in 2013 by the European Union. It was established with the goal of fighting antibiotic resistances and optimizing antibiotic usage and patients’ care in both countries. These goals can only be achieved by comparison of differences between the two countries in prescribing patterns and usage of antibiotics, and related emerging inconveniences and disadvantages. In order to make the evaluation as efficient and automated as possible, a relevant part of this project is placed in the IT field. For this purpose, a highly normalized and standardized database was designed, managed by a web platform that collects data concerning antibiotic resistance and data on surveys among populations at risk. The proposed platform is at a prototypal level, currently available on the internet. 64 patients have already been inserted.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.